Florian Wegwitz

1.6k total citations
44 papers, 1.0k citations indexed

About

Florian Wegwitz is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Florian Wegwitz has authored 44 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 18 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Florian Wegwitz's work include Ubiquitin and proteasome pathways (11 papers), Cancer Cells and Metastasis (10 papers) and Epigenetics and DNA Methylation (7 papers). Florian Wegwitz is often cited by papers focused on Ubiquitin and proteasome pathways (11 papers), Cancer Cells and Metastasis (10 papers) and Epigenetics and DNA Methylation (7 papers). Florian Wegwitz collaborates with scholars based in Germany, United States and United Kingdom. Florian Wegwitz's co-authors include Steven A. Johnsen, Robyn Laura Kosinsky, Wolfgang Deppert, Vijayalakshmi Kari, Markus Glatzel, Zeynab Najafova, Katharina Jannasch, Vivek Kumar Mishra, Hermann C. Altmeppen and Sankari Nagarajan and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and PLoS ONE.

In The Last Decade

Florian Wegwitz

44 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Florian Wegwitz Germany 21 812 287 176 118 81 44 1.0k
Andrew L. Ji United States 8 986 1.2× 275 1.0× 250 1.4× 282 2.4× 63 0.8× 15 1.3k
Katherine Dunn Canada 10 850 1.0× 313 1.1× 286 1.6× 96 0.8× 67 0.8× 14 1.2k
Fabienne Maurer Switzerland 15 598 0.7× 151 0.5× 147 0.8× 81 0.7× 73 0.9× 24 916
Vanesa Lafarga Spain 18 1.2k 1.4× 368 1.3× 126 0.7× 83 0.7× 97 1.2× 32 1.4k
Xiong Jin South Korea 20 630 0.8× 299 1.0× 275 1.6× 148 1.3× 34 0.4× 42 1.1k
David F. Allison United States 14 1.2k 1.5× 235 0.8× 203 1.2× 144 1.2× 85 1.0× 16 1.4k
Eugene Ke United States 10 785 1.0× 285 1.0× 280 1.6× 124 1.1× 127 1.6× 20 1.2k
Christelle Benaud France 15 623 0.8× 197 0.7× 241 1.4× 160 1.4× 63 0.8× 21 1.1k
Michael Zager United States 6 781 1.0× 159 0.6× 153 0.9× 99 0.8× 84 1.0× 12 1.0k
Alexander Kukalev Sweden 12 914 1.1× 304 1.1× 185 1.1× 60 0.5× 94 1.2× 21 1.1k

Countries citing papers authored by Florian Wegwitz

Since Specialization
Citations

This map shows the geographic impact of Florian Wegwitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florian Wegwitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florian Wegwitz more than expected).

Fields of papers citing papers by Florian Wegwitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florian Wegwitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florian Wegwitz. The network helps show where Florian Wegwitz may publish in the future.

Co-authorship network of co-authors of Florian Wegwitz

This figure shows the co-authorship network connecting the top 25 collaborators of Florian Wegwitz. A scholar is included among the top collaborators of Florian Wegwitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florian Wegwitz. Florian Wegwitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rehling, Peter, et al.. (2024). USP22 supports the aggressive behavior of basal-like breast cancer by stimulating cellular respiration. Cell Communication and Signaling. 22(1). 120–120. 6 indexed citations
2.
Kusch, Kathrin, Christof M. Kramm, Christian Dullin, et al.. (2023). RNF40 epigenetically modulates glycolysis to support the aggressiveness of basal-like breast cancer. Cell Death and Disease. 14(9). 641–641. 8 indexed citations
3.
Hardt, Olaf, et al.. (2023). Basal‐like mammary carcinomas stimulate cancer stem cell properties through AXL‐signaling to induce chemotherapy resistance. International Journal of Cancer. 152(9). 1916–1932. 4 indexed citations
4.
Klein, Lukas, Florian Wegwitz, Elisa Espinet, et al.. (2022). Axon guidance receptor ROBO3 modulates subtype identity and prognosis via AXL-associated inflammatory network in pancreatic cancer. JCI Insight. 7(16). 5 indexed citations
5.
Müller, Claudia, Stefan Kalkhof, Henning Urlaub, et al.. (2022). ROBO3s: a novel ROBO3 short isoform promoting breast cancer aggressiveness. Cell Death and Disease. 13(9). 762–762. 2 indexed citations
6.
Neeße, Albrecht, et al.. (2021). Suppression of HSF1 activity by wildtype p53 creates a driving force for p53 loss-of-heterozygosity. Nature Communications. 12(1). 4019–4019. 15 indexed citations
7.
Bedi, Upasana, et al.. (2021). USP22 promotes HER2-driven mammary carcinoma aggressiveness by suppressing the unfolded protein response. Oncogene. 40(23). 4004–4018. 29 indexed citations
8.
Kosinsky, Robyn Laura, Ana P. Kutschat, Asha Nair, et al.. (2021). RNF20 and RNF40 regulate vitamin D receptor-dependent signaling in inflammatory bowel disease. Cell Death and Differentiation. 28(11). 3161–3175. 19 indexed citations
9.
Wegwitz, Florian, et al.. (2020). Influence of ARHGAP29 on the Invasion of Mesenchymal-Transformed Breast Cancer Cells. Cells. 9(12). 2616–2616. 7 indexed citations
10.
Najafova, Zeynab, Peng Liu, Florian Wegwitz, et al.. (2020). RNF40 exerts stage-dependent functions in differentiating osteoblasts and is essential for bone cell crosstalk. Cell Death and Differentiation. 28(2). 700–714. 19 indexed citations
11.
Wegwitz, Florian, Robyn Laura Kosinsky, Markus Glatzel, et al.. (2020). The histone H2B ubiquitin ligase RNF40 is required for HER2-driven mammary tumorigenesis. Cell Death and Disease. 11(10). 873–873. 14 indexed citations
12.
Kosinsky, Robyn Laura, et al.. (2019). USP22-dependent HSP90AB1 expression promotes resistance to HSP90 inhibition in mammary and colorectal cancer. Cell Death and Disease. 10(12). 911–911. 33 indexed citations
13.
Kari, Vijayalakshmi, Julia Kitz, Frank Krämer, et al.. (2019). The histone methyltransferase DOT1L is required for proper DNA damage response, DNA repair, and modulates chemotherapy responsiveness. Clinical Epigenetics. 11(1). 4–4. 49 indexed citations
14.
Puig, Berta, Hermann C. Altmeppen, Luise Linsenmeier, et al.. (2019). GPI-anchor signal sequence influences PrPC sorting, shedding and signalling, and impacts on different pathomechanistic aspects of prion disease in mice. PLoS Pathogens. 15(1). e1007520–e1007520. 31 indexed citations
15.
Mishra, Vivek Kumar, Malayannan Subramaniam, Vijayalakshmi Kari, et al.. (2017). Krüppel-like Transcription Factor KLF10 Suppresses TGFβ-Induced Epithelial-to-Mesenchymal Transition via a Negative Feedback Mechanism. Cancer Research. 77(9). 2387–2400. 47 indexed citations
16.
Mishra, Vivek Kumar, Florian Wegwitz, Robyn Laura Kosinsky, et al.. (2017). Histone deacetylase class-I inhibition promotes epithelial gene expression in pancreatic cancer cells in a BRD4- and MYC-dependent manner. Nucleic Acids Research. 45(11). 6334–6349. 65 indexed citations
17.
Xie, Wanhua, Sankari Nagarajan, Simon J. Baumgart, et al.. (2017). RNF40 regulates gene expression in an epigenetic context-dependent manner. Genome biology. 18(1). 32–32. 42 indexed citations
18.
Otto, Benjamin, Christina Heinlein, Florian Wegwitz, et al.. (2012). Low‐grade and high‐grade mammary carcinomas in WAP‐T transgenic mice are independent entities distinguished by Met expression. International Journal of Cancer. 132(6). 1300–1310. 16 indexed citations
19.
Hirner, Heidrun, Çagatay Güneş, Joachim Bischof, et al.. (2012). Impaired CK1 Delta Activity Attenuates SV40-Induced Cellular Transformation In Vitro and Mouse Mammary Carcinogenesis In Vivo. PLoS ONE. 7(1). e29709–e29709. 33 indexed citations
20.
Jannasch, Katharina, Christian Dullin, Christina Heinlein, et al.. (2009). Detection of different tumor growth kinetics in single transgenic mice with oncogene‐induced mammary carcinomas by flat‐panel volume computed tomography. International Journal of Cancer. 125(1). 62–70. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew L. Ji Breakdown of academic impact, for papers by Katherine Dunn Breakdown of academic impact, for papers by Fabienne Maurer Breakdown of academic impact, for papers by Vanesa Lafarga Breakdown of academic impact, for papers by Xiong Jin Breakdown of academic impact, for papers by David F. Allison Breakdown of academic impact, for papers by Eugene Ke Breakdown of academic impact, for papers by Christelle Benaud Breakdown of academic impact, for papers by Michael Zager Breakdown of academic impact, for papers by Alexander Kukalev
Rankless by CCL
2026